12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.

      The Journal of Allergy and Clinical Immunology

      Anti-Inflammatory Agents, Non-Steroidal, administration & dosage, therapeutic use, Dendritic Cells, drug effects, immunology, metabolism, Down-Regulation, genetics, Gene Expression, Gene Expression Profiling, Humans, Immunoglobulin G, Interferon-gamma, antagonists & inhibitors, Interleukin-17, Interleukin-1beta, Interleukin-8, Myeloid Cells, Oligonucleotide Array Sequence Analysis, Psoriasis, drug therapy, Receptors, Tumor Necrosis Factor, Signal Transduction, Skin, pathology, T-Lymphocytes, Helper-Inducer, Tumor Necrosis Factor-alpha, Up-Regulation

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          TNF inhibitors have revolutionized the treatment of psoriasis vulgaris as well as psoriatic and rheumatoid arthritis and Crohn disease. Despite our understanding that these agents block TNF, their complex mechanism of action in disease resolution is still unclear. To analyze globally the genomic effects of TNF inhibition in patients with psoriasis, and to compare genomic profiles of patients who responded or did not respond to treatment. In a clinical trial using etanercept TNF inhibitor to treat psoriasis vulgaris (n = 15), Affymetrix gene arrays were used to analyze gene profiles in lesional skin at multiple time points during drug treatment (baseline and weeks 1, 2, 4, and 12) compared with nonlesional skin. Patients were stratified as responders (n = 11) or nonresponders (n = 4) on the basis of histologic disease resolution. Cluster analysis was used to define gene sets that were modulated with similar magnitude and velocity over time. In responders, 4 clusters of downregulated genes and 3 clusters of upregulated genes were identified. Genes downmodulated most rapidly reflected direct inhibition of myeloid lineage immune genes. Upregulated genes included the stable dendritic cell population genes CD1c and CD207 (langerin). Comparison of responders and nonresponders revealed rapid downmodulation of innate IL-1beta and IL-8 sepsis cascade cytokines in both groups, but only responders downregulated IL-17 pathway genes to baseline levels. Although both responders and nonresponders to etanercept inactivated sepsis cascade cytokines, response to etanercept is dependent on inactivation of myeloid dendritic cell genes and inactivation of the T(H)17 immune response.

          Related collections

          Author and article information

          Journal
          19895991
          2852188
          10.1016/j.jaci.2009.08.046

          Comments

          Comment on this article